Rodrigo Jorge

Has Scientific Initiation (1993) and graduation (1994) from the Faculty of Medicine of Ribeirão Preto, University of São Paulo (1994). He completed his doctorate in Medicine, in the Ophthalmology course at the Faculty of Medicine of Ribeirão Preto, University of São Paulo (1999). Specialization in Retina and Vitreous at Escola Paulista de Medicina (1997-1998) and at Bascom Palmer Eye Institute (2001). In 2007 he obtained the title of Associate Professor at the Faculty of Medicine of Ribeirão Preto, becoming Associate Professor at the University of São Paulo. Specialization in Ocular Oncology at Wills Eye Institute, Thomas Jefferson University, Philadelphia (2014). Specialization in Pediatric Retinal Surgery, Associated Retinal Consultants, Royal Oak, Michigan (2019). Has experience in Medicine, with emphasis on Ophthalmology, working mainly on topics related to retinology, ocular oncology, retinopathy of prematurity and macular diseases: Retina, Diabetic Retinopathy, Diabetic Macular Edema, Vitreoretinal Surgery, Combined Retina and cataracts, macular surgeries (macular hole and epiretinal membrane), age-related macular degeneration, Optical coherence tomography, Anti-angiogenics (ranibizumab, bevacizumab, aflibercept), Triamcinolone and Prolonged drug release. In 1998, he founded the Retina and Vitreous Service of the HCFMRP-USP and has already contributed to the training of 72 specialists in Retina and Vitreous, 9 Master's students, 21 Doctoral students and 4 post-doctoral students.Among the graduates, the following stand out: Abenor Moreira Minaré Filho, Professor at the State University of Western Paraná, Unioeste; Alexandre de Faria Rodrigues, Teaching Assistant at the Faculty of Medicine of Marília -FAMEMA; José Afonso Ramos Filho, Collaborating Physician at HCFMRP-USP; Jefferson Augusto Santana Ribeiro, Professor at the State University of Amazonas, Marco Antônio Bonini Filho; Professor at the Federal University of Mato Grosso do Sul; Rafael de Oliveira, Adjunct Professor of the Discipline of Clinical and Surgical Ophthalmology at the Federal University of Rondônia-UNIR, Leticia Barroso, Professor at the Catholic University of Brasilia and, more recently, Natacha Biscaro Junqueira, Professor at the Federal University of Mato Grosso do Sul. In 2015, he founded the Ocular Oncology Service of the HCFMRP-USP and instituted the treatment for Retinoblastoma and Choroidal Melanoma with brachytherapy through the Unified Health System in the region of Ribeirão Preto. He has already trained 4 specialists in Ocular Oncology and supervised a Doctoral Thesis in this subspecialty. In the research area, he is part of the INOVASENSE Research Group on Pharmaceutical Research and Innovation at CNPq, together with Professors from the Federal University of Minas Gerais and the Ezequiel Dias Foundation. Responsible for the first human intravitreal implantation of an antibiotic for the treatment of ocular toxoplasmosis and the first human intravitreal implantation of a carbonic anhydrase inhibitor for the treatment of macular edema. In ocular oncology, he tested the first combined treatment of melphalan intra-arterial chemotherapy and ruthenium brachytherapy for the treatment of primary choroidal melanoma. (Source: Lattes Curriculum)